Browsing by Author "Marquez, Maria"
Now showing 1 - 3 of 3
Results Per Page
Sort Options
- ItemPrevalence of Sleep Related Symptoms in Four Latin American Cities(2008) Torre-Bouscoulet, Luis; Carlos Vazquez-Garcia, Juan; Muino, Adriana; Marquez, Maria; Victorina Lopez, Maria; Montes de Oca, Maria; Talamo, Carlos; Valdivia, Gonzalo; Pertuze, Julio; Menezes, Ana Maria B.; Perez-Padilla, RogelioStudy Objectives: to estimate the prevalence of the most common sleep related symptoms (SRS) in the metropolitan areas of Mexico City, Montevideo (Uruguay), Santiago (Chile), and Caracas (Venezuela).
- ItemSpirometry reference values after inhalation of 200 mu g of Salbutamol(ELSEVIER ESPANA SLU, 2007) Perez Padilla, Rogelio; Torre Bouscoulet, Luis; Carlos Vazquez Garcia, Juan; Muino, Adriana; Marquez, Maria; Victorina Lopez, Maria; de Oca, Maria Montes; Talamo, Carlos; Valdivia, Gonzalo; Pertuze, Julio; Jardim, Jose; Menezes, Ana Maria B.; Grp PLATINOOBJECTIVE: The criteria for disease severity established by the Global Initiative for Chronic Obstructive Lung Disease are based on forced expiratory volume in I second (FEV) expressed as a percentage of the predicted value after application of a bronchodilator. This study aims to determine postbronchodilator spirometry reference values.
- ItemTreatment of chronic obstructive pulmonary disease in 5 Latin American cities: The PLATINO study(ELSEVIER ESPANA SLU, 2008) Varela, Maria Victorina Lopez; Muino, Adriana; Padille, Rogelio Perez; Jardim, Jose Roberto; Talamo, Carlos; de Oca, Maria Montes; Valdivia, Gonzalo; Pertuze, Julio; Halbert, Ron; Menezes, Ana Maria; Marquez, Maria; Hallal, Pedro; Moreno, Dolores; Rosa, Fernanda; Carnelier, AquilesOBJECTIVE: PLATINO project is a population-based study designed to determine the prevalence of chronic obstructive pulmonary disease (COPD) in S (a) over tildeo Paulo, Brazil; Mexico City, Mexico; Montevideo, Uruguay; Santiago de Chile, Chile; and Caracas, Venezuela. The objective of this portion of PLATINO was to describe preventive and pharmacological treatment of COPD patients and factors associated with such treatment.
